| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 12.148 | 21.747 | 13.127 | 20.355 | 10.305 | 17.427 | 23.261 | 19.253 | 21.010 |
| Total Income - EUR | - | 12.148 | 21.747 | 13.129 | 20.356 | 10.305 | 17.427 | 23.261 | 19.253 | 21.010 |
| Total Expenses - EUR | - | 6.564 | 16.012 | 9.694 | 18.457 | 9.148 | 15.924 | 17.929 | 14.420 | 11.860 |
| Gross Profit/Loss - EUR | - | 5.584 | 5.735 | 3.435 | 1.898 | 1.157 | 1.503 | 5.333 | 4.833 | 9.149 |
| Net Profit/Loss - EUR | - | 5.219 | 5.082 | 3.041 | 1.288 | 853 | 991 | 4.718 | 3.528 | 7.254 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alicardio 16 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 215 | 0 | 0 | 901 | 625 | 2.460 | 3.496 | 2.715 | 2.039 |
| Current Assets | - | 5.951 | 7.491 | 3.382 | 3.695 | 4.750 | 3.181 | 3.052 | 2.069 | 6.848 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.286 | 4.988 | 884 | 1.565 | 1.520 | 1.595 | 1.849 | 322 | 6.582 |
| Cash | - | 3.665 | 2.503 | 2.498 | 2.130 | 3.230 | 1.586 | 1.203 | 1.746 | 266 |
| Shareholders Funds | - | 5.264 | 5.222 | 3.225 | 4.451 | 5.219 | 3.967 | 5.048 | 3.945 | 7.760 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.072 | 2.435 | 157 | 145 | 155 | 1.674 | 1.500 | 839 | 1.127 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alicardio 16 Srl